🎯
LATEST VERIFIED ALGORITHMIC EXECUTION
Quantitative engine captured a net profit of +19.26% on $OC in just 23h 32m.
PCV
$PCVX
🔒 US EquitiesVaxcyte Inc
AVG HISTORICAL GAP
-1.10%
MAX GAP RECORD
-8.91%
🔒 PRO INSTITUTIONAL
AI PREDICTIVE WIN RATE
94.2%
REVEAL PRO DIRECTION ⚡
SENTINEL HISTORICAL GAP VIEWER
// $PCVX
📊 1-YEAR TIMELINE (GAPS PLOTTED)
🔮 SIMULATE SETUP 🔒
GAP INSPECTION // PLAYBACK PROTOCOL
$PCVX
HISTORICAL GAP OCCURRENCE
Analyzing price jump between T-1 close and opening auction.
EVENT DATE—
GAP MAGNITUDE—
T-1 CLOSE—
OPEN PRICE—
AI DIRECTIONPRO ONLY 🔒
Bullish Opening Gap
Bearish Opening Gap
T-1 Close Baseline
CATALYSTS & GAP HISTORY
| Aug 05, 2026 Earnings Release 2026-08-05 (AFTER CLOSE) |
-1.34%
|
| May 06, 2026 Earnings Release 2026-05-06 (AFTER CLOSE) |
-3.66%
|
| Feb 24, 2026 Earnings Release 2026-02-24 (AFTER CLOSE) |
-5.84%
|
| Nov 04, 2025 Earnings Release 2025-11-04 (AFTER CLOSE) |
-1.04%
|
| Aug 06, 2025 Earnings Release 2025-08-06 (AFTER CLOSE) |
-8.91%
|
| May 07, 2025 Earnings Release 2025-05-07 (AFTER CLOSE) |
+4.52%
|
| Feb 25, 2025 Earnings Release 2025-02-25 (AFTER CLOSE) |
+4.50%
|
| Nov 05, 2024 Earnings Release 2024-11-05 (AFTER CLOSE) |
+6.53%
|
VOLATILITY & GAP BIAS
AVG GAP MOVE
3.3%
Bullish Gaps (4)
Bearish Gaps (9)
Neutral / Flat (2)
📖 Intelligence Summary
Vaxcyte, Inc. engages in the development of vaccines for infectious diseases. It focuses on conjugate vaccines and protein-based vaccines developed through the Sutro Biopharma's Xpress CF Platform, a cell-free protein synthesis technology. The company was founded by Grant E. Pickering and Jeff Fairman on November 27, 2013, and is headquartered…
NEXT UPCOMING PREDICTIVE SIGNAL
STRONG BUY / TARGET +35%
🔓 REVEAL AI SIGNAL & TARGETS ↗